Developer docs
API playgroundTry for free, no card

Search company profiles

LUTO Research

Full company profile

uuid0005666

Namestring
LUTO Research
Legal namestring
Luto Research Limited
Websiteurl
luto.co.uk
Company typeenum
Private
Founded yearint
2004
Descriptiontext

LUTO Research (legal name: Luto Research Limited) is a UK-headquartered healthcare communications and usability testing firm founded in 2004 as the Leeds University Testing Organisation, originating from the University of Leeds. The company writes, designs, and tests clear health communications — including Patient Information Leaflets (PILs), Instructions for Use (IFUs), Participant Information Sheets and Informed Consent Forms for clinical trials, EU Clinical Trial Lay Summaries, and Risk Management / REMS materials — and validates their readability through iterative user testing with lay participants, patients, and healthcare professionals. Its proprietary 'Audience Design Step' (ADS) methodology and ISO 9001 accredited Readability User Testing underpin the service, alongside hybrid usability testing for medical devices, eye tracking, heuristic evaluation, and expert usability review. The firm operates physical usability testing labs in Broughton near Skipton (UK headquarters), Basel (Switzerland), and Chicago (USA), enabling multi-jurisdictional participant recruitment and regulatory submission support for clients in the EU and US.

LUTO serves global pharmaceutical companies, medical device manufacturers, regulators, charities, government bodies, and healthcare providers (named references include Forte Medical and Macmillan Cancer Support). Revenue is generated through project-based professional services engagements priced on a quote basis per scope, with services spanning content writing, design enhancement, user testing with full ISO 9001 documented reports, recruitment of representative patient panels, and additive modules such as eye tracking and heuristic evaluation. An associated sub-brand, iC Display, extends into digital storytelling, signage, motion graphics, and web/app development for visual content applications. Marketing is largely sales-led with industry visibility through the CEO's roles with the British Medical Association Patient Information Awards and the Patient Information Forum.

The firm is privately held with one disclosed external capital event: a £250,000 investment from NPIF – FW Capital in July 2021 to support Covid-19 recovery and global expansion. The senior leadership team is led by Chief Executive Wayne Middleton (appointed April 2015), with founder Professor Theo Raynor serving as Co-Founder & Academic Advisor. The team comprises information design specialists, graphic designers, writers, medical information experts, nurses, pharmacists, psychologists, project managers, interviewers, and academics.

Short descriptiontext

LUTO Research is a UK-based healthcare communications and usability testing firm that writes, designs, and user-tests Patient Information Leaflets, Instructions for Use, clinical trial materials, and lay summaries for pharmaceutical, medical device, regulator, and charity clients across the UK, Switzerland, and the US.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBradford, United Kingdom
HQ citystring
Bradford
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
healthcare communications, usability testing, readability testing, patient information leaflets, medical device IFUs
Industry3 codes
PRIMARYHLAGAOAG
Medical Affairs, Scientific Communications & HEOR FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGAOAC
Medical Writing & Clinical Documentation FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGALAF
Medical Affairs Scientific Communications (MSL Support/Scientific Response)
NAICS code4 codes
  • Scientific Research and Development Services5417
  • Research and Development in the Physical, Engineering, and Life Sciences54171
  • Other Scientific and Technical Consulting Services541690
  • Professional, Scientific, and Technical Services54
SIC code3 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Testing Laboratories8734
  • Services-Health Services8000
Product category
Healthcare Communications Services
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Healthcare Communications Services
TypeProfessional Services
Description

Professional services for creating, designing, and testing health communications including Patient Information Leaflets, Instructions for Use, clinical trial materials, lay summaries, and risk management documentation. Services are tailored to regulatory requirements in EU and US markets.

luto.co.uk
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
1Digital Project Assistant salary: circa £24,000 plus benefits
ModelOtherBilling cadenceOther
Notes

One career posting indicates internal salary structure. External project pricing is custom-quoted based on scope.

luto.co.uk
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

LUTO Research designs, writes, and tests healthcare communications for pharmaceutical companies, medical device manufacturers, regulators, and charities. Services include the development and usability/readability testing of Patient Information Leaflets (PILs), Instructions for Use (IFUs), clinical trial materials (Participant Information Sheets, Informed Consent Forms, lay summaries), and risk management documentation. All materials are tested with real patients, carers, and healthcare professionals to ensure regulatory compliance and patient understanding.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Better informed clinical trial participants make better treatment decisions and demonstrate improved adherence
+1 more record
Product overview1 text field

LUTO Research operates as a healthcare communications company offering a unified portfolio of user testing and information design services. The core offering centers on Usability Testing and Readability User Testing services, supported by specialized testing methodologies (Eye Tracking, Heuristic Evaluation, Expert Usability Review). The Create suite includes Instructions for Use (IFU), Patient Information Leaflets, Clinical Trial documentation (Informed Consent Forms and Lay Summaries), and Risk Management materials. Creative Services are delivered through the iC Display sub-brand offering digital signage and motion graphics. All services are delivered through usability facilities in Yorkshire (UK), Basel (Switzerland), and Chicago (USA), with human-centered testing approaches involving real patients, carers, and healthcare professionals.

Product and service9 records
1Usability Testing
CategoryUsability Testing
Description

Hands-on usability testing service for medical device Instructions for Use (IFU) and other healthcare communications, using hybrid methodology combining User and Usability Testing techniques. Offered as formative testing during development or summative validation, conducted in dedicated usability labs.

2Readability User Testing
CategoryReadability Testing
Description

Readability testing for Patient Information Leaflets (PILs) and Instructions for Use (IFUs) across the EU and US markets, conducted under ISO 9001 accredited methodology. For pharmaceutical companies and medical device manufacturers needing to demonstrate readability and user comprehension.

3Instructions for Use (IFU) Development
CategoryMedical Device Documentation
Description

Development of clear and understandable Instructions for Use (IFUs), instruction manuals, and packaging for medical devices. Includes human factors service to test IFUs with iterative, formative development process involving users at key stages. For medical device manufacturers needing regulatory-compliant IFU materials.

4Patient Information Leaflets (PILs)
CategoryPharmaceutical Communications
Description

Enhancement of Package Leaflet clarity and readability using the proprietary Audience Design Step methodology, ensuring regulatory compliance with EU QRD template requirements. Includes writing, design enhancement, readability testing, and bridging services. For pharmaceutical companies.

5Clinical Trials - Informed Consent Forms
CategoryClinical Trial Documentation
Description

Production, redesign, refinement and alignment of Participant Information Sheets (PIS) and Informed Consent Forms (ICF) for clinical trials. Brings together patient information experience, information design principles and User Testing methodology. For pharmaceutical companies and clinical trial sponsors.

6Clinical Trial Lay Summaries
CategoryClinical Trial Documentation
Description

Turning clinical study reports into lay-friendly summaries per EU Clinical Trials Regulation No. 536/2014. Includes writing, enhancing existing summaries, template creation, graphic design, and User Testing. Services include development, user engagement, lay person review, and bespoke training. For pharmaceutical companies and clinical trial sponsors.

7Risk Management Documentation
CategoryPharmaceutical Communications
Description

Production of Risk Management information for clinical trials, training packages, and teaching tools. Includes redesign of RMP lay summaries and Risk Evaluation and Mitigation Strategy (REMS) program materials including medication guides, training tools, and educational materials. For pharmaceutical companies.

8User Engagement Research
CategoryUser Research
Description

User-centered research approach using various tools and techniques to gather insight from patients, carers and health professionals. Services include recruitment, surveys, telephone interviews, 1-to-1 interviews, focus groups and workshops. For pharmaceutical, medical device, and healthcare clients needing patient insights.

9iC Display (Creative Services)
CategoryCreative Services
Description

Digital storytelling and digital signage service creating high-impact visual content. Includes motion graphics, signage and wayfinding, digital screens and CMS, web and app development, and brand strategy services. For clients needing creative digital content production.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Clariness is a clinical trial patient engagement and recruitment company producing study information, patient-facing materials, and usability-tested study communications for pharma sponsors. It is a direct peer to Luto as both focus on enhancing participant-facing clinical trial documents through patient-centred design and testing.

TypeBroad incumbent
Description

ICON plc is a global CRO offering clinical trial services across all phases. It is comparable as a potential competitor for pharma trial-communications budgets, though ICON's primary focus is clinical operations and biometrics rather than the readability/user testing niche where Luto specialises.

TypeDirect peer
Description

Healthwise is a US non-profit producing patient education materials with rigorous readability and plain-language standards. It is comparable to Luto as both specialise in evidence-based, plain-language patient communications and readability testing, though Healthwise focuses on consumer-facing content while Luto serves pharma and medical device clients.

TypeBroad incumbent
Description

Langland is a UK-based health communications agency providing advertising, medical communications, and patient engagement services to pharma. It is comparable to Luto as both serve the same pharma client base with regulated health-communications deliverables, but Langland operates at much larger scale across creative, medical education, and advertising rather than specialising in usability/readability testing.

TypeBroad incumbent
Description

McCann Health is a large global health communications network offering advertising, medical communications, and patient engagement. It is comparable because both compete for pharma health-communications budgets, but McCann operates a broad portfolio across many disciplines whereas Luto is a specialist in usability and readability testing of patient materials.

TypeDirect peer
Description

BBK Worldwide is a clinical trial patient recruitment and engagement firm offering study materials, informed consent design, and patient-facing communications. It is a direct peer to Luto because both produce patient information sheets, ICFs, and trial lay materials, and compete for similar pharma trial operations budgets.

TypeEmerging player
Description

Dudnyk is a specialty healthcare agency focused on biotech and rare disease communications. It is comparable because both serve pharma clients producing patient-facing communications including clinical trial and disease-education materials, though Dudnyk emphasises brand strategy while Luto specialises in user testing and readability.

TypeOthers
Description

Veeva Systems provides cloud software for life sciences including medical affairs, regulatory, and clinical operations. It is comparable to Luto only as a thematically adjacent technology provider serving regulated communications workflows in pharma — not a direct competitor, but Veeva's growing medical communications modules could eventually overlap with Luto's content workstreams.

TypeBroad incumbent
Description

Clario (formerly ERT) is a clinical trial technology and endpoint services provider offering eCOA, imaging, and patient-centric trial solutions including instructions and training materials. It is comparable because both support clinical trial patient-facing materials, though Clario operates a broader technology platform rather than specialising in usability testing.

TypeBroad incumbent
Description

Real Chemistry is a healthcare marketing and communications firm offering advertising, medical affairs, and patient engagement services to pharma and biotech. It is comparable to Luto because both produce regulated patient and clinical trial communications, though Real Chemistry operates at far larger scale with a broad service portfolio.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

LUTO Research

Healthcare Communications Servicesluto.co.uk

LUTO Research is a UK-based healthcare communications and usability testing firm that writes, designs, and user-tests Patient Information Leaflets, Instructions for Use, clinical trial materials, and lay summaries for pharmaceutical, medical device, regulator, and charity clients across the UK, Switzerland, and the US.

What LUTO Research does

LUTO Research (legal name: Luto Research Limited) is a UK-headquartered healthcare communications and usability testing firm founded in 2004 as the Leeds University Testing Organisation, originating from the University of Leeds. The company writes, designs, and tests clear health communications — including Patient Information Leaflets (PILs), Instructions for Use (IFUs), Participant Information Sheets and Informed Consent Forms for clinical trials, EU Clinical Trial Lay Summaries, and Risk Management / REMS materials — and validates their readability through iterative user testing with lay participants, patients, and healthcare professionals. Its proprietary 'Audience Design Step' (ADS) methodology and ISO 9001 accredited Readability User Testing underpin the service, alongside hybrid usability testing for medical devices, eye tracking, heuristic evaluation, and expert usability review. The firm operates physical usability testing labs in Broughton near Skipton (UK headquarters), Basel (Switzerland), and Chicago (USA), enabling multi-jurisdictional participant recruitment and regulatory submission support for clients in the EU and US.

LUTO serves global pharmaceutical companies, medical device manufacturers, regulators, charities, government bodies, and healthcare providers (named references include Forte Medical and Macmillan Cancer Support). Revenue is generated through project-based professional services engagements priced on a quote basis per scope, with services spanning content writing, design enhancement, user testing with full ISO 9001 documented reports, recruitment of representative patient panels, and additive modules such as eye tracking and heuristic evaluation. An associated sub-brand, iC Display, extends into digital storytelling, signage, motion graphics, and web/app development for visual content applications. Marketing is largely sales-led with industry visibility through the CEO's roles with the British Medical Association Patient Information Awards and the Patient Information Forum.

The firm is privately held with one disclosed external capital event: a £250,000 investment from NPIF – FW Capital in July 2021 to support Covid-19 recovery and global expansion. The senior leadership team is led by Chief Executive Wayne Middleton (appointed April 2015), with founder Professor Theo Raynor serving as Co-Founder & Academic Advisor. The team comprises information design specialists, graphic designers, writers, medical information experts, nurses, pharmacists, psychologists, project managers, interviewers, and academics.

LUTO Research firmographics

Firmographics
Name
LUTO Research
Legal name
Luto Research Limited
Website
https://luto.co.uk
Company type
Private
Founded year
2004
Operating status
Operating
Headcount range
11–50 employees
Short description
LUTO Research is a UK-based healthcare communications and usability testing firm that writes, designs, and user-tests Patient Information Leaflets, Instructions for Use, clinical trial materials, and lay summaries for pharmaceutical, medical device, regulator, and charity clients across the UK, Switzerland, and the US.
Ownership category
akta.pro rank

LUTO Research industry classification

Industry
Product category
Healthcare Communications Services
NAICS
Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171), Other Scientific and Technical Consulting Services (541690), Professional, Scientific, and Technical Services (54)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734), Services-Health Services (8000)
akta.pro industry
PRIMARYHLAGAOAG
Medical Affairs, Scientific Communications & HEOR FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGAOAC
Medical Writing & Clinical Documentation FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGALAF
Medical Affairs Scientific Communications (MSL Support/Scientific Response)

Keywords

  • Healthcare communications
  • Usability testing
  • Readability testing
  • Patient information leaflets
  • Medical device IFUs

Where LUTO Research is headquartered

Location

Headquarters

HQ city
Bradford
HQ country
United Kingdom
HQ region
Europe

Offices3 records

Markets served

LUTO Research business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Healthcare Communications Services: Professional services for creating, designing, and testing health communications including Patient Information Leaflets, Instructions for Use, clinical trial materials, lay summaries, and risk management documentation. Services are tailored to regulatory requirements in EU and US markets.

Pricing tiers

ModelBillingPrice
OtherOtherDigital Project Assistant salary: circa £24,000 plus benefits

Go-to-market motion2 records

Distribution channels1 record

Marketing channels5 records

LUTO Research product offering

Product offering

Core offering

LUTO Research designs, writes, and tests healthcare communications for pharmaceutical companies, medical device manufacturers, regulators, and charities. Services include the development and usability/readability testing of Patient Information Leaflets (PILs), Instructions for Use (IFUs), clinical trial materials (Participant Information Sheets, Informed Consent Forms, lay summaries), and risk management documentation. All materials are tested with real patients, carers, and healthcare professionals to ensure regulatory compliance and patient understanding.

Product overview

LUTO Research operates as a healthcare communications company offering a unified portfolio of user testing and information design services. The core offering centers on Usability Testing and Readability User Testing services, supported by specialized testing methodologies (Eye Tracking, Heuristic Evaluation, Expert Usability Review). The Create suite includes Instructions for Use (IFU), Patient Information Leaflets, Clinical Trial documentation (Informed Consent Forms and Lay Summaries), and Risk Management materials. Creative Services are delivered through the iC Display sub-brand offering digital signage and motion graphics. All services are delivered through usability facilities in Yorkshire (UK), Basel (Switzerland), and Chicago (USA), with human-centered testing approaches involving real patients, carers, and healthcare professionals.

Differentiator

Problem solved

Functional benefit

Products and services

  • Usability Testing Hands-on usability testing service for medical device Instructions for Use (IFU) and other healthcare communications, using hybrid methodology combining User and Usability Testing techniques. Offered as formative testing during development or summative validation, conducted in dedicated usability labs.
  • Readability User Testing Readability testing for Patient Information Leaflets (PILs) and Instructions for Use (IFUs) across the EU and US markets, conducted under ISO 9001 accredited methodology. For pharmaceutical companies and medical device manufacturers needing to demonstrate readability and user comprehension.
  • Instructions for Use (IFU) Development Development of clear and understandable Instructions for Use (IFUs), instruction manuals, and packaging for medical devices. Includes human factors service to test IFUs with iterative, formative development process involving users at key stages. For medical device manufacturers needing regulatory-compliant IFU materials.
  • Patient Information Leaflets (PILs) Enhancement of Package Leaflet clarity and readability using the proprietary Audience Design Step methodology, ensuring regulatory compliance with EU QRD template requirements. Includes writing, design enhancement, readability testing, and bridging services. For pharmaceutical companies.
  • Clinical Trials - Informed Consent Forms Production, redesign, refinement and alignment of Participant Information Sheets (PIS) and Informed Consent Forms (ICF) for clinical trials. Brings together patient information experience, information design principles and User Testing methodology. For pharmaceutical companies and clinical trial sponsors.
  • Clinical Trial Lay Summaries Turning clinical study reports into lay-friendly summaries per EU Clinical Trials Regulation No. 536/2014. Includes writing, enhancing existing summaries, template creation, graphic design, and User Testing. Services include development, user engagement, lay person review, and bespoke training. For pharmaceutical companies and clinical trial sponsors.
  • Risk Management Documentation Production of Risk Management information for clinical trials, training packages, and teaching tools. Includes redesign of RMP lay summaries and Risk Evaluation and Mitigation Strategy (REMS) program materials including medication guides, training tools, and educational materials. For pharmaceutical companies.
  • User Engagement Research User-centered research approach using various tools and techniques to gather insight from patients, carers and health professionals. Services include recruitment, surveys, telephone interviews, 1-to-1 interviews, focus groups and workshops. For pharmaceutical, medical device, and healthcare clients needing patient insights.
  • iC Display (Creative Services) Digital storytelling and digital signage service creating high-impact visual content. Includes motion graphics, signage and wayfinding, digital screens and CMS, web and app development, and brand strategy services. For clients needing creative digital content production.

Quantifiable outcome

  • Better informed clinical trial participants make better treatment decisions and demonstrate improved adherence
  • +1 more outcomes

Companies that use LUTO Research

Customer profile

Named customers2 records

Segments4 records

Ideal customer profiles4 records

LUTO Research technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

LUTO Research partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

LUTO Research competitors and assessment

Company assessment

Direct peers

  • Clariness: Clariness is a clinical trial patient engagement and recruitment company producing study information, patient-facing materials, and usability-tested study communications for pharma sponsors. It is a direct peer to Luto as both focus on enhancing participant-facing clinical trial documents through patient-centred design and testing.
  • Healthwise: Healthwise is a US non-profit producing patient education materials with rigorous readability and plain-language standards. It is comparable to Luto as both specialise in evidence-based, plain-language patient communications and readability testing, though Healthwise focuses on consumer-facing content while Luto serves pharma and medical device clients.
  • BBK Worldwide: BBK Worldwide is a clinical trial patient recruitment and engagement firm offering study materials, informed consent design, and patient-facing communications. It is a direct peer to Luto because both produce patient information sheets, ICFs, and trial lay materials, and compete for similar pharma trial operations budgets.

Broad incumbents

  • ICON plc: ICON plc is a global CRO offering clinical trial services across all phases. It is comparable as a potential competitor for pharma trial-communications budgets, though ICON's primary focus is clinical operations and biometrics rather than the readability/user testing niche where Luto specialises.
  • Langland: Langland is a UK-based health communications agency providing advertising, medical communications, and patient engagement services to pharma. It is comparable to Luto as both serve the same pharma client base with regulated health-communications deliverables, but Langland operates at much larger scale across creative, medical education, and advertising rather than specialising in usability/readability testing.
  • McCann Health: McCann Health is a large global health communications network offering advertising, medical communications, and patient engagement. It is comparable because both compete for pharma health-communications budgets, but McCann operates a broad portfolio across many disciplines whereas Luto is a specialist in usability and readability testing of patient materials.
  • ERT (Clario): Clario (formerly ERT) is a clinical trial technology and endpoint services provider offering eCOA, imaging, and patient-centric trial solutions including instructions and training materials. It is comparable because both support clinical trial patient-facing materials, though Clario operates a broader technology platform rather than specialising in usability testing.
  • Real Chemistry: Real Chemistry is a healthcare marketing and communications firm offering advertising, medical affairs, and patient engagement services to pharma and biotech. It is comparable to Luto because both produce regulated patient and clinical trial communications, though Real Chemistry operates at far larger scale with a broad service portfolio.

Emerging players

  • Dudnyk: Dudnyk is a specialty healthcare agency focused on biotech and rare disease communications. It is comparable because both serve pharma clients producing patient-facing communications including clinical trial and disease-education materials, though Dudnyk emphasises brand strategy while Luto specialises in user testing and readability.

Others

  • Veeva Systems: Veeva Systems provides cloud software for life sciences including medical affairs, regulatory, and clinical operations. It is comparable to Luto only as a thematically adjacent technology provider serving regulated communications workflows in pharma — not a direct competitor, but Veeva's growing medical communications modules could eventually overlap with Luto's content workstreams.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

LUTO Research social profiles

Digital presence

LUTO Research compliance and trust

Trust signal

Compliance1 record

LUTO Research financial estimates

Financial estimate

Revenue estimate

Valuation estimate

LUTO Research leadership team

Management profile

Number of profiles

Profiles10 records

LUTO Research funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

LUTO Research M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LUTO Research

What does LUTO Research do?

LUTO Research designs, writes, and tests healthcare communications for pharmaceutical companies, medical device manufacturers, regulators, and charities. Services include the development and usability/readability testing of Patient Information Leaflets (PILs), Instructions for Use (IFUs), clinical trial materials (Participant Information Sheets, Informed Consent Forms, lay summaries), and risk management documentation. All materials are tested with real patients, carers, and healthcare professionals to ensure regulatory compliance and patient understanding.

Is LUTO Research a public or private company?

LUTO Research is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was LUTO Research founded?

LUTO Research was founded in 2004. It employs 11 to 50 people.

Where is LUTO Research based?

LUTO Research is headquartered in Bradford, United Kingdom, in the Europe region.

How does LUTO Research make money?

One revenue line is on record: healthcare Communications Services.

Who are LUTO Research's main competitors?

Direct peers on record are Clariness, Healthwise and BBK Worldwide. Broad incumbents are ICON plc, Langland, McCann Health, ERT (Clario) and Real Chemistry. Dudnyk is listed as an emerging player. Veeva Systems is listed as an others.

Does LUTO Research have an API?

No public API is recorded for LUTO Research.

What industry is LUTO Research in?

LUTO Research's product category is Healthcare Communications Services. Its primary akta.pro industry code is HLAGAOAG, Medical Affairs, Scientific Communications & HEOR FSP, with a secondary code of HLAGAOAC, Medical Writing & Clinical Documentation FSP. Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals